the potential for early identification of relapse in dlbcl using serial ctdna sampling
Published 5 months ago • 64 plays • Length 3:10Download video MP4
Download video MP3
Similar videos
-
3:59
using enhanced ctdna profiling to identify molecular determinants of response in r/r mcl
-
3:05
the clinical use of circulating tumor dna in t-cell lymphomas
-
1:09
interim analysis of anbal-cel for r/r dlbcl
-
1:38
using circulating tumor dna in lymphoma: clinical trials & clinical practice
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:23
the influence of early pid diagnosis on transplant success
-
3:51
novel developments in relapsed/refractory hl: checkpoint inhibitors, bispecifics and car-t cells
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
1:52
critical insight into therapeutic progress for ctcl
-
3:54
the use of tarc as a diagnostic biomarker in hodgkin lymphoma
-
1:07
a future study linking tumor genetics with cll dynamics
-
1:18
the impact of the approval of pirtobrutinib on the treatment landscape for patients with cll
-
2:04
imc-001: preliminary results of novel pd-l1 inhibitor for r/r extranodal nk/t cell lymphoma
-
1:19
single-cell sequencing of circulating tumor cells to predict progression from mgus/smm
-
0:58
real-world monitoring of circulating tumor dna to predict cancer recurrence
-
1:21
novel approaches to harnessing the immune system in lymphoma
-
1:31
five-year follow-up of olutasidenib for idh1-mutated r/r aml
-
1:34
dr. bidard on the clinical utility of circulating tumor cell count in breast cancer
-
1:19
the importance of studying circulating tumor cell lines